HIV Surveillance Summary Georgia, 2017 HIV/AIDS Epidemiology Section Epidemiology Program Division of Health Protection Georgia Department of Public Health 2017 Georgia HIV Surveillance Summary Page 1 The HIV Surveillance Summary, Georgia 2017 is published by the Georgia Department of Public Health (DPH), HIV/AIDS Epidemiology Section (HAES), 2 Peachtree Street NW, Atlanta, Georgia 30303. Data are presented from known diagnoses and laboratory reports entered into the Georgia Enhanced HIV/AIDS Reporting System (eHARS). All data are provisional. The HIV Surveillance Summary, Georgia 2017 is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated. SUGGESTED CITATION: Georgia Department of Public Health, HIV/AIDS Epidemiology Section HIV Surveillance Summary, Georgia 2017, https://dph.georgia.gov/data-fact-sheet-summaries, Published February 2019, [Accessed: date] ACKNOWLEDGEMENTS: Publication of this report was made possible with the contributions of the Georgia DPH HAES Core HIV Surveillance staff, HIV Case Report Forms submitted by Georgia health care facility staff, HIV infection related laboratory test results transmitted by laboratory facilities in Georgia, data matches with other DPH programs, and the ongoing efforts of multiple individuals from public and private sector organizations dedicated to improving surveillance, prevention, testing, and care of persons living with HIV infection. Georgia HIV Core Surveillance Team contributors: Lauren Barrineau-Vejjajiva, Thelma Fannin, Latosha Johnson, Rodriques Lambert, Mildred McGainey, Latoya Moss, Kim Norris, Rama Namballa, Doris Pearson, A. Eugene Pennisi, Akilah Spratling, Sylve Rawls, Emory Searcy, and Gerriana Willams. This report was prepared by the following staff from the Georgia Department of Public Health: Wendy Wen, MPH; Pascale Wortley, MD, MPH; Cherie Drenzek, DVM, MS. 2017 Georgia HIV Surveillance Summary Page 2 Table of Contents INTRODUCTION ....................................................................................................................................................................... 5 TECHNICAL NOTES .................................................................................................................................................................. 6 Definitions ........................................................................................................................................................................... 7 References .......................................................................................................................................................................... 8 TABLES..................................................................................................................................................................................... 9 HIV Diagnoses and persons living with HIV, Georgia, 2017 .............................................................................................. 10 Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2017 ................................................ 10 Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2017.......................... 11 Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2017 ...................... 12 Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2017 .. 13 Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2016 ....................... 14 Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2016 ............. 15 Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2017......... 16 Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of 12/31/2017 ................................................................................................................................................................... 17 HIV Diagnoses and Persons Living with HIV by Public Health District .............................................................................. 18 Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2017 ........................................... 18 Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2017........................................ 19 Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2017 .................................... 20 Table 12 HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2017 ............................. 21 Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2017 ........................................ 22 Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2017 ...................................... 23 Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2017................................. 24 Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2017 ....................................... 25 Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2017....................................... 26 Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2017 ........................................ 27 Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2017 ....................................... 28 Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2017......................................... 29 Table 21. HIV Diagnoses and Persons Living with HIV, District 7 Columbus), Georgia, 2017 ....................................... 30 Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2017..................................... 31 Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2017........................................ 32 2017 Georgia HIV Surveillance Summary Page 3 Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2017 ................................... 33 Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2017 ................................... 34 Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2017 ........................................ 35 HIV Diagnoses and Persons Living with HIV, Atlanta MSA.............................................................................................. 366 Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2017 ........... 36 Late Diagnoses by Public Health District and Atlanta MSA .............................................................................................. 37 Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2017 ...... 37 Public Health District and County Rates ........................................................................................................................... 38 Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2017 ......................................................................................................................... 38 Distribution of General Population by Race/Ethnicity...................................................................................................... 43 Table 30. Distribution of the general population by race/ethnicity, Georgia 2016...................................................... 43 HIV/AIDS RESOURCES: .......................................................................................................................................................... 44 2017 Georgia HIV Surveillance Summary Page 4 INTRODUCTION HIV infection remains an important public health problem in the state of Georgia. As of the end of 2017, there were 58,808 persons living with HIV in Georgia, and 2,698 persons were diagnosed in 2017. The number of persons living with HIV continues to increase, because of effective therapies now available. Based on the Centers for Disease Control and Prevention's 2017 HIV Surveillance Report, Georgia was ranked the fifth highest in the nation for both the total number of new diagnoses of HIV infection among adults and adolescents and for the number of persons living with HIV infection, after Florida, California, Texas, and New York1. Georgia ranked 1st in the rate of HIV diagnosis among adults and adolescents, and 4th in the rate of persons living with HIV. Monitoring the HIV/AIDS epidemic and understanding the burden of HIV infection in Georgia are essential for meeting the goals stated in the 2020 National HIV/AIDS Strategy to: 1) reduce HIV infections; 2) increase access to care and optimize health outcomes for persons living with HIV; 3) reduce HIV-related health disparities, and; 4) achieve a more coordinated national response to the HIV epidemic. Information on the Georgia HIV care continuum can be found in a separate report at the following web page: https://dph.georgia.gov/hiv-care-continuum. 2017 Georgia HIV Surveillance Summary Page 5 TECHNICAL NOTES Georgia statutes and regulations (O.C.G.A. 3112-2(b)) require healthcare providers (such as nurses, nurse practitioners, doctors, physician assistants) licensed in the state of Georgia to report all cases of HIV infection and/or Stage 3 (AIDS) to the Georgia DPH within seven days of diagnosis2. Laboratories licensed in the state of Georgia are required to report all HIV-related laboratory test results within 7 days. The information is used to monitor the HIV/AIDS epidemic in Georgia and guide program planning and evaluation. The data presented in the accompanying tables are based on confidential case reports collected through the Georgia DPH enhanced HIV/AIDS Reporting System (eHARS). AIDS reporting began in the early 1980s, and HIV reporting began in Georgia on December 31, 2003. Electronic transmission of laboratory test results began in 2011. Receipt of CD4 counts and viral load tests make it possible to estimate the HIV Care Continuum for persons with a diagnosis of HIV infection in the state of Georgia (reports are available at: https://dph.georgia.gov/hiv-carecontinuum). HIV diagnoses include persons with a diagnosis of HIV infection, regardless of the stage of disease at diagnosis, who were residents of Georgia at the time of diagnosis. Persons living with HIV are those with a residence in the state of Georgia, based on current information available in the Georgia HIV/AIDS surveillance system, regardless of where they resided at the time of diagnosis. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. Information on transmission category is missing for 30% of cases. Multiple imputation, a statistical approach, is used to replace each missing transmission category with a set of plausible values that represent the uncertainty about the true, but missing, value3. The methods were applied to adult and adolescent, but not pediatric cases. Multiple imputation is considered by the Centers for Disease Control and Prevention to be the best method for redistribution of missing data in large databases. Transmission category is shown with missing data, and after multiple imputation. Cases missing race/ethnicity are not assigned a risk through multiple imputation. This report includes surveillance data reported through December 31, 2017 for cases diagnosed through December 31, 2016. This report is limited to cases diagnosed through December 2016 to take into account delays in reporting, and to allow for obtaining follow up information on reported cases. Persons for whom the current identity box "transgender" was checked on the case report form are classified as transgender. Because providers often do not complete all case report forms fields, the numbers reported here are most likely an underestimate. Additionally, because the current identity fields were 2017 Georgia HIV Surveillance Summary Page 6 added to the case report form in 2007, prevalent counts of HIV among transgender persons are incomplete. For data presented at the Public Health District or MSA level, all cells <5 observations are censored in accordance with the Georgia Department of Public Health HIV Surveillance Security and Confidentiality Guidelines. Definitions HIV DIAGNOSES are cases diagnosed between January 1 and December 31, 2017, with an address at the time of HIV diagnosis was in Georgia, and who were reported to the Georgia Department of Public Health by December 31 2018, regardless of stage at diagnosis. This group includes persons whose initial diagnosis is Stage 3 (AIDS). LATE DIAGNOSES are the subset of HIV diagnoses who are found to be Stage 3 (AIDS) within 12 months of HIV diagnosis date. Such persons are termed late diagnoses because their advanced stage at diagnosis indicates that they were most likely infected for many years before diagnosis. STAGE 3 (AIDS) DIAGNOSES include two groups: 1) persons newly diagnosed with HIV in 2017, found to meet the definition for Stage 3 (AIDS) at diagnosis, and with an address at or near the time of Stage 3 diagnosis in Georgia; and, 2) persons found to meet the Stage 3 definition in 2017 with an address at or near the time of Stage 3 diagnosis in Georgia, regardless of the date of their initial HIV diagnosis. PERSONS LIVING WITH HIV INFECTION are persons diagnosed by December 31, 2017, who are not known to be deceased, and for whom the most recent address available is in Georgia. PERSONS LIVING WITH HIV, EVER STAGE 3 are persons diagnosed by December 31, 2017, who are not known to be deceased, for whom the most recent address available is in Georgia, and who met the case definition for Stage 3 (AIDS) at some point. TRANSMISSION CATEGORIES presented in this report follow the standards created by the Centers for Disease Control and Prevention (CDC) and have been used for many years. According to the CDC, transmission category is the term for the classification of cases that summarizes a person's possible HIV risk factors. The summary classification results from selecting the one most likely risk factor to have been responsible for HIV transmission from the presumed hierarchical order of probability. For surveillance purposes, HIV and AIDS cases are counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV infection are classified in the transmission category according to the behavior that is most likely to have resulted in transmission. The exception is men who report sexual contact with other men and injection drug use; this group makes up a separate transmission category. Persons whose transmission category is classified as heterosexual contact are persons who report heterosexual contact specifically with a person known to have or be at high risk for HIV infection (e.g., an injection drug user/IDU). 2017 Georgia HIV Surveillance Summary Page 7 The term high risk is not included in the transmission category label for heterosexual contact in the tables because heterosexual contact itself is the risk factor most likely to have been responsible for transmission. However, the Table 3 footnote regarding this category clarifies how the data are defined: "heterosexual contact with a person known to have, or to be at high risk for, HIV infection". CURRENT RESIDENCE Current address is determined using the date of the most recently-entered residential address as of 12/31/2017 into the Georgia eHARS. The number of persons living with HIV is based on current address. presented for case numbers less than 12 because these rates have relative standard errors greater than 30% and are considered unreliable. PERCENTAGES: Total percentages may not add up to 100% due to rounding. COUNTS: Counts in the gender, race/ethnicity, and age categories may not add up to the overall totals due to a small number of cases with missing information (<2 percent). References VITAL STATUS: Persons are assumed to be alive unless otherwise documented or reported. The Georgia DPH performs an annual match of the eHARS database with the Georgia Vital Records death data, the National Death Index and the Social Security Death Index to ascertain vital status. RATES: Denominators for population rates are based on the 2017 estimates of the Georgia resident population retrieved from the Georgia Department of Public Health, Office of Health Indicators for Planning (OHIP). Rates are per 100,000 population. Rates are not 1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2017; vol.29. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/ cdc-hiv-surveillance-report-2016-vol-29.pdf 2. Department of Public Health, Rules and regulations 290-48.11 (2003); Official Code of Georgia Annotated (O.C.G.A.) 31-22-9.2 (2011) 3. Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:61827. 2017 Georgia HIV Surveillance Summary Page 8 TABLES 2017 Georgia HIV Surveillance Summary Page 9 HIV Diagnoses and persons living with HIV, Georgia, 2017 Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2017 HIV Diagnoses (all stages) Late HIV Diagnoses1 N %* N %* row % Total 2,698 613 Gender Identity Male 2,089 77.3 472 77.0 22.6 Female 587 21.7 138 22.5 23.5 Transgender 22 0.8 3 0.3 13.6 Race/Ethnicity Black/Non Hispanic 1,908 70.6 425 69.3 22.3 White/Non Hispanic 443 16.4 102 16.6 23.0 Hispanic/Latino, Any Race 199 7.4 58 9.5 29.1 American Indian/Alaska Native 2 0.1 0 0.0 0.0 Asian/Native Hawaiian/Pacific Islander 27 1.0 8 1.3 29.6 Multiple races 62 2.3 13 2.1 21.0 Age Group at Diagnosis (Years) <13 7 0.3 3 0.5 42.9 13-19 141 5.2 18 2.9 12.8 20-29 1,049 38.8 149 24.3 14.2 30-39 672 24.9 153 25.0 22.8 40-49 401 14.8 138 22.5 34.4 50-59 304 11.3 108 17.6 35.5 60+ 127 4.7 44 7.2 34.6 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 1,462 54.1 289 47.1 19.8 Injection drug use (IDU) 52 1.9 16 2.6 30.8 MSM-IDU 29 1.1 7 1.1 24.1 Heterosexual contact3 517 19.1 155 25.3 30.0 Perinatal/other pediatric4 7 0.2 3 0.3 42.9 Unknown 636 23.5 143 23.5 22.5 Transmission Category (Adjusted)5 MSM-IDU 1,734 64.2 346 56.5 20.0 IDU 83 3.1 26 4.2 31.3 MSM-IDU Heterosexual contact3 38 1.4 773 28.6 9 1.5 23.7 223 36.4 28.8 Perinatal/other pediatric4 7 0.2 3 0.3 42.9 Stage 3 (AIDS) Diagnoses2 N %* 1,152 857 74.4 281 24.4 14 1.0 841 73.0 186 16.1 79 6.9 0 0.0 11 1.0 34 3.0 6 0.5 18 1.6 269 23.4 299 26.0 260 22.6 210 18.2 90 7.8 558 48.4 35 3.0 24 2.1 239 20.7 6 0.5 290 25.2 673 58.4 60 5.2 31 2.6 379 32.9 6 0.5 *Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2017 Georgia HIV Surveillance Summary Page 10 Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2017 HIV Diagnoses (all stages) Late HIV Diagnoses1 Stage 3 (AIDS) Diagnoses2 Total Race/Ethnicity Black/Non Hispanic N %* N %* row % N 2,085 100.0 471 100.0 22.6 857 1,429 68.5 309 65.6 21.6 604 %* 100.0 70.5 White/Non Hispanic 369 17.7 82 17.4 22.2 148 17.3 Hispanic/Latino, Any Race 168 8.1 53 11.3 31.5 65 7.6 American Indian/Alaska Native 2 0.1 0 0.0 0.0 0 0.0 Asian/Native Hawaiian/Pacific Islander 23 1.1 7 1.5 30.4 10 1.2 Multiple races 53 2.5 13 2.8 24.5 29 3.4 Age Group at Diagnosis (Years) <13 4 0.2 3 0.6 75.0 6 0.7 13-19 114 5.5 16 3.4 14.0 15 1.8 20-29 888 42.6 126 26.8 14.2 222 25.9 30-39 513 24.6 122 25.9 23.8 236 27.5 40-49 279 13.4 99 21.0 35.5 173 20.2 50-59 207 9.9 75 15.9 36.2 151 17.6 60+ 80 3.8 30 6.4 37.5 54 6.3 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 1,440 69.1 287 60.9 19.9 545 63.6 Injection drug use (IDU) 29 1.4 5 1.1 17.2 20 2.3 MSM-IDU Heterosexual contact3 Perinatal/other pediatric4 29 1.4 7 1.5 24.1 24 2.8 203 9.7 85 18.0 41.9 104 12.1 4 0.1 3 0.4 75.0 6 0.7 Unknown 380 18.3 84 18.0 22.1 158 18.4 Transmission Category (Adjusted) MSM 1,715 82.3 344 73.1 20.1 660 77.0 IDU 44 2.1 9 1.9 20.5 30 3.5 MSM-IDU Heterosexual contact3 Perinatal/other pediatric4 38 1.8 9 2.0 23.7 31 3.6 244 11.7 99 21.1 40.6 128 14.9 4 0.1 3 0.4 75.0 6 0.7 * Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2017 Georgia HIV Surveillance Summary Page 11 Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2017 HIV Diagnoses (all stages) Late HIV Diagnoses1 Stage 3 (AIDS) Diagnoses2 Total Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted) Injection drug use Heterosexual contact3 Perinatal/other pediatric4 N %* N %* row % N 587 100.0 138 100.0 23.5 281 457 77.9 113 81.9 24.7 224 72 12.3 20 14.5 27.8 38 28 4.8 4 2.9 14.3 13 4 0.7 1 0.7 25.0 1 9 1.5 0 0.0 0.0 5 3 0.5 0 0.0 0.0 0 26 4.4 2 1.4 7.7 3 143 24.4 21 15.2 14.6 37 153 26.1 30 21.7 21.0 62 120 20.4 38 27.5 31.7 85 95 16.2 33 23.9 35.7 58 47 8.0 14 10.1 29.7 36 22 3.7 314 53.5 3 0.3 247 42.2 9 6.5 40.9 14 69 50.0 22.0 135 0 1.5 66.0 0 60 43.5 24.3 134 38 6.5 14 10.5 36.8 29 528 90.0 124 89.5 23.5 251 3 0.3 0 1 %* 100.0 79.7 13.5 4.6 0.4 1.8 0.0 1.4 13.2 22.1 30.2 20.7 12.8 5.0 48.0 1.0 47.0 10.2 89.4 * Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2017 Georgia HIV Surveillance Summary Page 12 Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2017 HIV Diagnoses (all stages) Late HIV Diagnoses1 Stage 3 (AIDS) Diagnoses2 Total Gender Identity Transgender Male-to-Female Transgender Unknown Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Age Group at Diagnosis (Years) 13-19 20-29 30-39 40-49 50-59 Transmission Category (Unadjusted) Sexual transmissson3 Injection drug use Sexual contact and injection drug use Unknown Transmission Category (Adjusted)4 Sexual transmissson3 Injection drug use Sexual contact and injection drug use Unknown N %* N %* row N %* % 21 95.5 2 66.7 9.5 12 85.7 1 4.5 1 33.3 100.0 2 14.3 19 86.4 2 66.7 10.5 13 92.9 2 9.1 0 0.0 0.0 0 0.0 1 4.5 1 33.3 100.0 1 7.1 1 4.5 0 0.0 0.0 0 0.0 13 59.1 2 66.7 15.4 11 78.6 5 22.7 0 0.0 0.0 1 7.1 1 4.5 0 0.0 0.0 1 7.1 2 9.1 1 33.3 50.0 1 7.1 20 90.9 2 66.7 10.0 13 92.9 1 4.5 1 33.3 100.0 1 7.1 0 0 0.0 0.0 0 0.0 1 4.5 0 0.0 0.0 0 0.0 21 95.5 2 66.7 9.5 13 92.9 1 4.5 1 33.3 100.0 1 7.1 0 0.0 0 0.0 0.0 0 0.0 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Includes sex with male and probable heterosexual transmission as noted in medical chart. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2017 Georgia HIV Surveillance Summary Page 13 Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2016 PLWH Ever Stage 3 (AIDS)1 N %* N %* Total 58,808 30,719 Gender Identity Male 44,350 75.4 23,240 75.7 Female 13,879 23.6 7,201 23.4 Transgender 509 0.9 259 0.8 Race/Ethnicity Black/Non Hispanic 40,105 68.2 21,235 69.1 White/Non Hispanic 11,178 19.0 5,805 18.9 Hispanic/Latino, Any Race 3,816 6.5 2,012 6.6 American Indian/Alaska Native 30 0.1 10 0.0 Asian/Native Hawaiian/Pacific Islander 279 0.5 110 0.4 Multiple races 2,388 4.1 1,358 4.4 Current Age Group (Years) <13 101 0.2 24 0.1 13-19 347 0.6 55 0.2 20-29 7,496 12.7 2,014 6.6 30-39 12,666 21.5 5,278 17.2 40-49 13,880 23.6 7,801 25.4 50-59 16,343 27.8 10,406 33.9 60+ 7,962 13.5 5,138 16.7 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 28,476 48.4 14,661 47.7 Injection drug use (IDU) 2,534 4.3 1,781 5.8 MSM-IDU 1,900 3.2 1,267 4.1 Heterosexual contactt2 9,299 15.8 5,324 17.3 Adult Other3 565 1.0 297 1.0 Perinatal/other pediatric4 101 0.2 24 0.1 Unknown 15,933 27.1 7,365 24.0 Transmission Category (Adjusted)5 MSM-IDU 35,885 61.0 18,068 58.8 IDU 3,745 6.4 2,475 8.1 MSM-IDU 2,358 4.0 1,518 4.9 Heterosexual contactt2 15,143 25.7 8,144 26.5 Adult Other3 565 1.0 297 1.0 Perinatal/other pediatric4 101 0.2 24 0.1 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion. 2017 Georgia HIV Surveillance Summary Page 14 Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2016 PLWH Ever Stage 3 (AIDS)1 Total Race/Ethnicity Black/Non Hispanic N 44,350 28,933 %* 100.0 65.2 N 23,240 15,298 %* 100.0 65.8 White/Non Hispanic 9,612 21.7 5,066 21.8 Hispanic/Latino, Any Race 3,017 6.8 1,611 6.9 American Indian/Alaska Native 23 0.1 7 0.0 Asian/Native Hawaiian/Pacific Islander 216 0.5 87 0.4 Multiple races 1,817 4.1 1,027 4.4 Current Age Group (Years) <13 49 0.1 14 0.1 13-19 219 0.5 35 0.2 20-29 6,311 14.2 1,668 7.2 30-39 9,787 22.1 4,112 17.7 40-49 9,933 22.4 5,594 24.1 50-59 12,317 27.8 7,998 34.4 60+ 5,726 12.9 3,817 16.4 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 28,069 63.3 14,464 62.2 Injection drug use (IDU) 1,467 3.3 1,073 4.6 MSM-IDU 1,880 4.2 1,257 5.4 Heterosexual contactt2 2,413 5.4 1,514 6.5 Adult Other3 277 0.6 149 0.6 Perinatal/other pediatric4 49 0.1 14 0.1 Unknown 10,197 23.0 4,769 20.5 Transmission Category (Adjusted)5 MSM 35,468 80.0 17,865 76.9 IDU 2,050 4.6 1,420 6.1 MSM-IDU 2,337 5.3 1,507 6.5 Heterosexual contactt2 3,451 7.8 2,145 9.2 Adult Other3 277 0.6 149 0.6 Perinatal/other pediatric4 49 0.1 14 0.1 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion. 2017 Georgia HIV Surveillance Summary Page 15 Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2017 PLWH Ever Stage 3 (AIDS)1 Total Race/Ethnicity Black/Non Hispanic N 13,879 10,737 %* 100.0 77.4 N 7,201 5,727 %* 100.0 79.5 White/Non Hispanic 1,541 11.1 726 10.1 Hispanic/Latino, Any Race 754 5.4 373 5.2 American Indian/Alaska Native 6 0.0 2 0.0 Asian/Native Hawaiian/Pacific Islander 61 0.4 22 0.3 Multiple races 552 4.0 318 4.4 Current Age Group (Years) <13 51 0.4 9 0.1 13-19 125 0.9 20 0.3 20-29 1,053 7.6 307 4.3 30-39 2,681 19.3 1,077 15.0 40-49 3,805 27.4 2,123 29.5 50-59 3,943 28.4 2,358 32.7 60+ 2,216 16.0 1,306 18.1 Transmission Category (Unadjusted) Injection drug use 1,061 7.6 705 9.8 Heterosexual contactt2 6,860 49.4 3,793 52.7 Adult Other3 285 2.1 146 2.0 Perinatal/other pediatric4 51 0.3 9 0.1 Unknown 5,622 40.6 2,548 35.4 Transmission Category (Adjusted)5 Injection drug use 1,684 12.1 1,049 14.6 Heterosexual contact 11,633 83.8 5,963 82.8 Adult Other3 285 2.1 146 2.0 Perinatal/other pediatric4 51 0.3 9 0.1 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion. 2017 Georgia HIV Surveillance Summary Page 16 Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of 12/31/2017 PLWH Ever Stage 3 (AIDS)1 Total Gender Identity Transgender Male-to-Female N %* N %* 471 92.5 238 91.9 Transgender Female-to-Male 33 6.5 18 7.0 Unknown 5 1.0 3 1.2 Race/Ethnicity Black/Non Hispanic 423 83.1 206 79.5 White/Non Hispanic 22 4.3 11 4.2 Hispanic/Latino, Any Race 42 8.3 27 10.4 American Indian/Alaska Native 1 0.2 1 0.4 Asian/Native Hawaiian/Pacific Islander 2 0.4 1 0.4 Multiple races 19 3.7 13 5.0 Current Age Group (Years) 13-19 20-29 3 0.6 0.0 0 128 25.1 39 15.1 30-39 182 35.8 84 32.4 40-49 115 22.6 78 30.1 50-59 64 12.6 44 17.0 60+ 16 3.1 13 5.0 Transmission Category (Unadjusted) Sexual transmissson2 433 80.0 214 76.1 Injection drug use 4 0.8 2 0.8 Sexual contact and injection drug use 20 3.9 10 3.9 Adult other 3 0.6 2 0.8 Unknown 48 9.4 30 11.6 Transmission Category (Adjusted)3 Sexual transmissson2 476 81.9 240 78.4 Injection drug use 8 1.6 5 1.9 Sexual contact and injection drug use 21 4.1 11 4.1 Adult other 3 0.6 2 0.8 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2.Includes sex with male and probable heterosexual transmission as noted in medical chart 3. Adjusted for missing risk using multiple imputation methods 2017 Georgia HIV Surveillance Summary Page 17 HIV Diagnoses and Persons Living with HIV by Public Health District Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2017 Characteristics HIV diagnoses PLWH as of 12/31/2017 Total Gender Identity Male N % N % 51 100 1,089 100 39 76.5 802 73.6 Female 11 21.6 284 26.1 Transgender <5 -- <5 -- Race/Ethnicity Black/Non Hispanic 16 31.4 404 37.1 White/Non Hispanic 31 60.8 533 48.9 Hispanic/Latino, Any Race <5 -- 82 7.5 Asian/Native Hawaiian/Pacific Islander 0 0.0 <5 0.4 Multiple races 0 0.0 45 4.1 Age Group at Diagnosis (Years) <13 0 0.0 <5 -- 13-19 0 0.0 5 0.5 20-29 16 31.4 94 8.6 30-39 7 13.7 193 17.7 40-49 15 29.4 282 25.9 50-59 11 21.6 318 29.2 60+ <5 -- 193 17.7 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 25 49.0 447 41.0 Injection drug use (IDU) <5 -- 90 8.3 MSM-IDU <5 -- 45 4.1 Heterosexual contact1 8 15.7 154 14.1 Adult Other2 0 0.0 18 1.7 Perinatal/other pediatric3 0 0.0 <5 0.4 Unknown 15 29.4 331 30.4 Transmission Category (Adjusted)5 MSM 31 61.2 606 55.6 IDU <5 -- 114 10.5 MSM-IDU <5 -- 55 5.1 Heterosexual contact1 15 28.8 271 24.9 Adult Other2 0 0.0 18 1.7 Perinatal/other pediatric3 0 0.0 <5 0.4 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 18 Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown Age Group at Diagnosis (Years) 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Unknown HIV diagnoses N % 28 100 PLWH as of 12/31/2017 N % 677 100 23 82.1 539 79.6 <5 -- 133 19.6 0 0.0 <5 -- 5 17.9 131 19.4 14 50.0 387 57.2 6 21.4 106 15.7 <5 -- <5 -- <5 -- 34 5.0 <5 -- 16 2.4 <5 -- 5 0.7 11 39.3 74 10.9 9 32.1 128 18.9 5 17.9 168 24.8 <5 -- 198 29.2 0 0.0 104 15.4 18 64.3 351 51.8 <5 -- 29 4.3 <5 -- 34 5.0 <5 -- 82 12.1 0 0.0 6 0.9 <5 -- 175 25.8 18 64.3 430 63.5 <5 -- 43 6.3 <5 -- 41 6.1 5 18.9 141 20.8 0 0.0 6 0.9 <5 -- 16 2.4 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 19 Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2017 HIV Diagnoses PLWH as of 12/31/2017 Total Gender Identity Male N % N % 40 100 829 100 28 70.0 591 71.3 Female 12 30.0 231 27.9 Transgender 0 0.0 5 0.6 Race/Ethnicity Black/Non Hispanic 12 30.0 209 25.2 White/Non Hispanic 17 42.5 410 49.5 Hispanic/Latino, Any Race 9 22.5 129 15.6 American Indian/Alaska Native 0 0.0 <5 -- Asian/Native Hawaiian/Pacific Islander <5 -- 16 1.9 Multiple races <5 -- 36 4.3 Age Group at Diagnosis (Years) <13 0 0.0 <5 -- 13-19 7 17.5 9 1.1 20-29 11 27.5 85 10.3 30-39 7 17.5 154 18.6 40-49 10 25.0 218 26.3 50-59 <5 -- 236 28.5 60+ <5 -- 125 15.1 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 20 50.0 341 41.1 Injection drug use (IDU) <5 -- 44 5.3 MSM-IDU <5 -- 39 4.7 Heterosexual contact1 <5 -- 115 13.9 Adult Other2 0 0.0 10 1.2 Perinatal/other pediatric3 0 0.0 <5 -- Unknown 12 30.0 278 33.7 Transmission Category (Adjusted)5 MSM 23 56.8 464 56.0 IDU <5 -- 66 7.9 MSM-IDU <5 -- 46 5.6 Heterosexual contact1 12 30.5 215 25.9 Adult Other2 0 0.0 10 1.2 Perinatal/other pediatric3 0 0.0 <5 -- * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 20 Table 12. HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted) MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses PLWH as of 12/31/2017 N % N % 200 100 4,011 100 156 78.0 3,034 75.6 42 21.0 933 23.3 <5 -- 38 0.8 129 64.5 2,483 61.9 46 23.0 909 22.7 17 8.5 361 9.0 <5 -- 13 0.3 6 3.0 197 4.9 0 0.0 7 0.2 8 4.0 23 0.6 64 32.0 532 13.3 58 29.0 939 23.4 35 17.5 1,014 25.3 27 13.5 1,058 26.4 8 4.0 437 10.9 120 60.0 2,045 51.0 <5 -- 154 3.8 <5 -- 133 3.3 44 22.0 682 17.0 0 0.0 35 0.9 0 0.0 7 0.2 32 16.0 955 23.8 137 68.3 2,546 63.5 5 2.5 220 5.5 <5 -- 163 4.1 56 28.0 990 24.7 0 0.0 35 0.9 0 0.0 7 0.2 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 21 Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses N % 651 100 PLWH as of 12/31/2017 N % 16,770 100 540 82.9 13,957 83.2 101 15.5 2,609 15.6 8 1.2 181 1.0 490 75.3 12,043 71.8 89 13.7 2,940 17.5 38 5.8 820 4.9 <5 -- 11 0.1 5 0.8 56 0.3 15 2.3 670 4.0 0 0.0 10 0.1 25 3.8 48 0.3 276 42.4 2,048 12.2 174 26.7 3,876 23.1 84 12.9 4,011 23.9 62 9.5 4,597 27.4 30 4.6 2,174 13.0 428 65.7 9,933 59.2 9 1.4 702 4.2 <5 -- 710 4.2 108 16.6 1,911 11.4 0 0.0 90 0.5 0 0.0 10 0.0 102 15.7 3,414 20.4 480 73.8 11,821 70.5 13 1.9 933 5.6 6 0.9 825 4.9 139 21.4 2,856 17.0 0 0.0 90 0.5 0 0.0 10 0.0 * Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 22 Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses N % 146 100 PLWH as of 12/31/2017 N % 2,708 100 118 80.8 1,954 72.2 26 17.8 718 26.5 <5 -- 36 1.1 127 87.0 2,240 82.7 5 3.4 133 4.9 9 6.2 180 6.6 <5 -- <5 -- <5 -- 19 0.7 <5 -- 107 4.0 0 0.0 7 0.3 9 6.2 22 0.8 73 50.0 488 18.0 31 21.2 637 23.5 17 11.6 610 22.5 15 10.3 685 25.3 <5 -- 259 9.6 99 67.8 1,326 49.0 <5 -- 101 3.7 <5 -- 69 2.5 22 15.1 485 17.9 0 0.0 27 1.0 0 0.0 7 0.3 23 15.8 693 25.6 105 71.8 1,631 60.2 <5 -- 152 5.6 <5 -- 86 3.2 36 24.3 781 28.8 0 0.0 27 1.0 0 0.0 7 0.3 * Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 23 Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses N % 218 100 PLWH as of 12/31/2017 N % 4,091 100 167 76.6 2,932 71.7 47 21.6 1,113 27.2 <5 -- 39 1.0 135 61.9 2,489 60.8 27 12.4 752 18.4 37 17.0 537 13.1 0 0.0 <5 -- 10 4.6 62 1.5 <5 -- 165 4.0 0 0.0 6 0.1 16 7.3 28 0.7 83 38.1 544 13.3 49 22.5 891 21.8 39 17.9 1,072 26.2 28 12.8 1,093 26.7 <5 -- 457 11.2 109 50.0 1,904 46.5 5 2.3 125 3.1 0 0.0 100 2.4 25 11.5 701 17.1 0 0.0 54 1.3 0 0.0 6 0.1 79 36.2 1,201 29.4 143 65.7 2,443 59.7 9 4.2 207 5.1 <5 -- 130 3.2 58 26.8 1,166 28.5 0 0.0 54 1.3 0 0.0 6 0.1 * Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 24 Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 Unknown Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses N % 374 100 PLWH as of 12/31/2017 N % 9,926 100 297 79.4 7,920 79.8 75 20.1 1,894 19.1 <5 -- 101 1.0 296 79.1 7,093 71.5 35 9.4 1,688 17.0 27 7.2 612 6.2 0 0.0 <5 -- <5 -- 69 0.7 7 1.9 345 3.5 0 0.0 13 0.1 20 5.3 47 0.5 152 40.6 1,226 12.4 102 27.3 2,223 22.4 46 12.3 2,346 23.6 40 10.7 2,809 28.3 0 0.0 <5 -- 231 61.8 5,623 56.6 <5 -- 298 3.0 5 1.3 287 2.9 60 16.0 1,308 13.2 0 0.0 79 0.8 0 0.0 13 0.1 75 20.1 2,318 23.4 259 69.4 6,833 68.8 6 1.7 469 4.7 7 1.8 364 3.7 97 25.8 2,052 20.7 0 0.0 79 0.8 0 0.0 13 0.1 * Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 25 Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses PLWH as of 12/31/2017 N % N % 125 100 2,155 100 100 80.0 1,539 71.4 25 20.0 601 27.9 0 0.0 14 0.5 77 61.6 1,313 60.9 35 28.0 565 26.2 <5 -- 130 6.0 0 0.0 <5 -- 0 0.0 5 0.2 <5 -- 109 5.1 <5 -- 6 4.8 51 40.8 33 26.4 12 9.6 12 9.6 10 8.0 11 0.5 20 0.9 314 14.6 435 20.2 461 21.4 609 28.3 304 14.1 51 40.8 <5 -- 26 20.8 0 0.0 <5 -- 43 34.4 904 41.9 102 4.7 61 2.8 383 17.8 31 1.4 11 0.4 663 30.9 73 58.5 1,214 56.3 5 4.3 148 6.9 <5 -- 81 3.7 39 31.0 642 29.8 0 0.0 31 1.4 <5 -- 11 0.4 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 26 Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2017 Total Gender Identity Male Female Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Unknown Transmission Category (Adjusted)5 Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other HIV Diagnoses N % 25 100 PLWH as of 12/31/2017 N % 612 100 14 56.0 404 66.0 11 44.0 208 34.0 21 84.0 460 75.2 <5 -- 83 13.6 <5 -- 39 6.4 0 0.0 <5 -- 0 0.0 23 3.8 0 0.0 0 0.0 <5 -- <5 -- 5 20.0 52 8.5 10 40.0 103 16.8 <5 -- 150 24.5 <5 -- 203 33.2 <5 -- 101 16.5 7 28.0 145 23.7 <5 -- 43 7.0 0 0.0 16 2.6 12 48.0 139 22.7 0 0.0 <5 -- <5 -- 266 43.5 9 35.6 265 43.4 <5 -- 69 11.3 25 4.1 13 51.6 244 39.8 0 0.0 <5 -- * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 27 Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses N % 98 100 PLWH as of 12/31/2017 N % 2,203 100 70 70.7 1477 67.0 28 28.3 714 32.4 0 0.0 9 0.3 78 78.8 1649 74.9 16 16.2 336 15.3 0 0.0 89 4.0 0 0.0 <5 -- 0 0.0 <5 -- <5 -- 100 4.5 <5 -- 7 0.3 8 8.1 15 0.7 38 38.4 326 14.8 20 20.2 436 19.8 16 16.2 468 21.2 12 12.1 616 28.0 <5 -- 335 15.2 48 48.5 803 36.5 <5 -- 92 4.2 54 2.5 30 30.3 442 20.1 <5 -- 28 1.3 <5 -- 7 0.3 17 17.2 777 35.3 57 57.4 1116 50.7 <5 -- 166 7.5 0 0.0 76 3.5 35 34.9 787 35.7 <5 -- 28 1.3 <5 -- 7 0.3 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 28 Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Unknown Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Perinatal/other pediatric Transmission Category (Adjusted)5 Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Perinatal/other pediatric Unknown HIV Diagnoses N % PLWH as of 12/31/2017 N % 67 73.6 1,511 66.9 24 26.4 737 32.7 0 9 0.4 72 79.1 1,716 76.0 11 12.1 381 16.9 5 5.5 73 3.2 0 <5 <5 <5 <5 66 2.9 <5 17 0.8 0 5 5.5 45 49.5 19 20.9 5 5.5 9 9.9 8 8.8 6 0.3 49 2.2 284 12.6 373 16.5 433 19.2 692 30.7 420 18.6 47 51.6 0 <5 28 30.8 0 0 835 37.0 167 7.4 81 3.6 442 19.6 73 3.2 6 0.3 56 61.9 1,057 46.8 <5 241 10.7 <5 95 4.2 31 33.6 768 34.0 0 73 3.2 0 6 0.3 <5 17 0.8 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 29 Table 21. HIV Diagnoses and Persons Living with HIV, District 7 (Columbus), Georgia, 2017 Total Gender Identity Male HIV Diagnoses N % PLWH as of 12/31/2017 N % 77 64.7 1,183 65.5 Female Transgender 42 35.3 609 33.7 0 13 0.7 Race/Ethnicity Black/Non Hispanic 95 79.8 1,360 75.3 White/Non Hispanic Hispanic/Latino, Any Race 11 9.2 232 12.8 8 6.7 82 4.5 American Indian/Alaska Native 0 Asian/Native Hawaiian/Pacific Islander 0 <5 0.1 <5 0.2 Multiple races Unknown <5 2.5 73 4.0 <5 1.7 54 3.0 Age Group at Diagnosis (Years) <13 13-19 <5 1.7 7 0.4 5 4.2 13 0.7 20-29 30-39 39 32.8 228 12.6 27 22.7 352 19.5 40-49 50-59 25 21.0 433 24.0 12 10.1 491 27.2 60+ 9 7.6 282 15.6 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) 37 31.1 568 31.5 <5 1.7 95 5.3 MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown 38 2.1 33 27.7 434 24.0 0 18 1.0 <5 1.7 7 0.4 45 37.8 646 35.8 53 44.8 815 45.1 5 3.8 144 8.0 <5 0.6 52 2.9 57 47.5 715 39.6 0 18 1.0 <5 1.7 7 0.4 <5 1.7 54 3.0 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 30 Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown HIV Diagnoses PLWH as of 12/31/2017 N % N % 42 61.8 26 38.2 0 50 73.5 7 10.3 5 7.4 <5 5 7.4 0 0 5 7.4 19 27.9 18 26.5 14 20.6 7 10.3 5 7.4 20 29.4 <5 <5 27 39.7 0 0 17 25.0 29 41.9 <5 <5 35 50.9 0 0 0 687 59.7 458 39.8 5 0.4 794 69.0 202 17.6 89 7.7 <5 56 4.9 9 0.8 <5 9 0.8 132 11.5 223 19.4 284 24.7 316 27.5 186 16.2 321 27.9 60 5.2 33 2.9 422 36.7 9 0.8 <5 305 26.5 430 37.3 84 7.3 40 3.4 578 50.2 9 0.8 <5 9 0.8 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 31 Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2017 HIV Diagnoses PLWH as of 12/31/2017 Total Gender Identity Male N % N % 56 64.4 1,092 61.4 Female 31 35.6 678 38.1 Transgender 0 9 0.5 Race/Ethnicity Black/Non Hispanic 75 86.2 1,449 81.5 White/Non Hispanic 7 8.0 178 10.0 Hispanic/Latino, Any Race <5 68 3.8 American Indian/Alaska Native 0 <5 Asian/Native Hawaiian/Pacific Islander 0 <5 Multiple races <5 70 3.9 Unknown 0 12 0.7 Age Group at Diagnosis (Years) <13 <5 7 0.4 13-19 5 5.7 21 1.2 20-29 33 37.9 254 14.3 30-39 20 23.0 355 20.0 40-49 9 10.3 379 21.3 50-59 10 11.5 482 27.1 60+ 9 10.3 280 15.7 Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) 30 34.5 575 32.3 Injection drug use (IDU) <5 66 3.7 MSM-IDU 0 30 1.7 Heterosexual contact1 28 32.2 411 23.1 Adult Other2 0 23 1.3 Perinatal/other pediatric3 <5 7 0.4 Unknown 27 31.0 667 37.5 Transmission Category (Adjusted)5 MSM 40 45.4 808 45.4 IDU <5 125 7.1 MSM-IDU 0 0.2 43 2.4 Heterosexual contact1 44 50.6 760 42.7 Adult Other2 0 23 1.3 Perinatal/other pediatric3 <5 7 0.4 *UPnekrncoewntnages may not add up to 100% due to rounding 1. Includes Asian, Pa0cific Islander, Native Hawaiian, Ameri1ca2n Indian, Alaska Na0t.i7ve, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 32 Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown HIV Diagnoses PLWH as of 12/31/2017 N % N % 100 75.2 1,867 67.7 32 24.1 879 31.9 <5 8 0.3 81 60.9 1,810 65.7 36 27.1 600 21.8 6 4.5 175 6.4 <5 8 0.3 6 4.5 131 4.8 <5 32 1.2 <5 7 0.3 7 5.3 12 0.4 51 38.3 359 13.0 30 22.6 511 18.5 19 14.3 555 20.1 18 13.5 823 29.9 7 5.3 488 17.7 70 52.6 994 36.1 <5 168 6.1 56 2.0 25 18.8 487 17.7 0 29 1.1 <5 7 0.2 36 27.8 1,015 36.9 85 63.7 1,398 50.7 <5 257 9.3 0 0.3 81 2.9 42 31.7 952 34.5 0 29 1.1 <5 7 0.2 <5 32 1.2 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 33 Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Multiple races Unknown Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown HIV Diagnoses N PLWH as of 12/31/2017 % N % 37 82.2 789 65.0 8 17.8 420 34.6 0 <5 26 57.8 775 63.9 9 20.0 259 21.4 7 15.6 88 7.3 <5 67 5.5 <5 24 2.0 <5 <5 0.1 <5 <5 0.2 11 24.4 149 12.3 12 26.7 223 18.4 9 20.0 286 23.6 6 13.3 355 29.3 <5 195 16.1 16 35.6 367 30.3 <5 65 5.4 <5 35 2.9 5 11.1 286 23.6 0 12 1.0 <5 <5 17 40.0 447 36.9 25 54.9 530 43.7 4 9.1 107 8.8 3 7.1 45 3.7 11 24.4 494 40.8 0 12 1.0 <5 <5 <5 24 2.0 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 34 Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown HIV Diagnoses N % PLWH as of 12/31/2017 N % 39 72.2 666 66.1 13 24.1 324 32.1 <5 17 1.6 32 59.3 556 55.2 17 31.5 324 32.1 5 9.3 74 7.3 0 5 0.5 0 41 4.1 0 8 0.8 0 <5 <5 12 1.2 17 31.5 113 11.2 12 22.2 219 21.7 13 24.1 245 24.3 5 9.3 261 25.9 <5 153 15.2 29 53.7 383 38.0 <5 58 5.8 <5 36 3.6 14 25.9 214 21.2 0 14 1.4 0 4 0.4 7 13.0 299 29.7 35 64.6 508 50.4 <5 82 8.2 <5 43 4.2 15 27.2 349 34.6 0 14 1.4 0 <5 0 8 0.8 * Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 35 HIV Diagnoses and Persons Living with HIV, Atlanta MSA Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2017 Total Gender Identity Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)5 MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV Diagnoses PLWH as of 12/31/2017 N % N % 1,427 80.2 32,271 78.8 331 18.6 8,215 20.1 18 1.0 411 0.9 1,276 71.7 28,077 68.6 265 14.9 7,625 18.6 141 7.9 2,771 6.8 <5 -- 22 0.1 23 1.3 236 0.6 37 2.1 1,648 4.0 <5 57 0.1 88 4.9 202 0.5 717 40.3 5,265 12.9 463 26.0 9,246 22.6 248 13.9 9,858 24.1 193 10.8 11,227 27.4 69 3.9 5,081 12.4 1,074 60.4 22,263 54.4 27 1.5 1,551 3.8 14 0.8 1,414 3.5 293 16.5 5,682 13.9 0 0.0 337 0.8 <5 -- 48 0.1 370 20.8 9,651 23.6 1,238 69.6 27,208 66.4 45 2.5 2,224 5.4 20 1.1 1,718 4.2 441 24.8 8,830 21.6 0 0.0 337 0.8 <5 -- 57 0.1 *Percents may not add up to 100 due to rounding 1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2. Includes American Indian, Alaska Native, Multiple races 3.Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Includes perinatal exposure, hemophilia, blood transfusion.5. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 6. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2017 Georgia HIV Surveillance Summary Page 36 Late Diagnoses by Public Health District and Atlanta MSA Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2017 Total 1-1 Northwest (Rome) 1-2 North Georgia (Dalton) 2 North (Gainesville) 3-1 Cobb-Douglas 3-2 Fulton 3-3 Clayton (Jonesboro) 3-4 East Metro (Lawrenceville) 3-5 DeKalb 4 LaGrange 5-1 South Central (Dublin) 5-2 North Central (Macon) 6 East Central (Augusta) 7 West Central (Columbus) 8-1 South (Valdosta) 8-2 Southwest (Albany) 9-1 Coastal (Savannah) 9-2 Southeast (Waycross) 10 Northeast (Athens) Unknown Health District HIV Diagnoses N 51 28 40 200 651 146 218 374 125 25 99 91 119 68 87 133 45 54 143 Late HIV Diagnoses Stage 3 [AIDS] within 12 months N row % 16 31.4 9 32.1 6 15.0 57 28.5 113 17.4 28 19.2 53 24.3 79 21.1 26 20.8 9 36.0 29 29.3 17 18.7 27 22.7 23 33.8 33 37.9 31 23.3 8 17.8 15 27.8 33 23.1 1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2017 Georgia HIV Surveillance Summary Page 37 Public Health District and County Rates Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2017 HIV Diagnoses (all stages) PLWH as of 12/31/2017 1-1 Northwest (Rome) BARTOW CO. CATOOSA CO. CHATTOOGA DADE CO. FLOYD CO. GORDON CO. HARALSON CO. PAULDING CO. POLK CO. WALKER CO. 1-2 North Georgia (Dalton) CHEROKEE CO. FANNIN CO. GILMER CO. MURRAY CO. PICKENS CO. WHITFIELD CO. 2 North (Gainesville) BANKS CO. DAWSON CO. FORSYTH CO. FRANKLIN CO. HABERSHAM CO. HART CO. HALL CO. LUMPKIN CO. RABUN CO. STEPHENS CO. TOWNS CO. UNION CO. WHITE CO. 3-1 Cobb-Douglas COBB CO. DOUGLAS CO. 3-2 Fulton N1 51 9 <5 <5 <5 12 <5 <5 12 6 5 28 22 0 0 0 <5 <5 40 0 <5 12 0 <5 <5 15 <5 0 <5 0 <5 <5 200 164 36 651 Rate/100,0002,3 7.6 ----- 12.3 --- 0.1 --- 5.8 8.9 0.0 0.0 0.0 --5.7 0.0 -5.3 0.0 --7.5 -0.0 -0.0 --22.2 21.7 25.0 62.5 N1 1,089 200 66 60 13 247 59 33 282 56 72 677 365 36 43 46 44 143 829 17 25 190 41 63 47 281 32 18 47 6 32 30 4011 3,428 583 16,770 Rate/100,0002,3 163.2 190.4 99.2 242.2 79.8 253.0 103.3 112.8 176.9 133.1 104.4 141.2 147.4 142.2 140.2 115.6 139.3 136.6 117.9 91.2 102.5 83.3 179.7 141.4 182.2 141.0 97.3 108.4 181.5 136.4 101.9 445.9 453.6 405.2 1610.3 2017 Georgia HIV Surveillance Summary Page 38 FULTON CO. 3-3 Clayton (Jonesboro) CLAYTON CO. 3-4 East Metro (Lawrenceville) GWINNETT CO. NEWTON CO. ROCKDALE CO. 3-5 DeKalb DEKALB CO. 4 LaGrange BUTTS CO. CARROLL CO. COWETA CO. FAYETTE CO. HEARD CO. HENRY CO. LAMAR CO. MERIWETHER CO. PIKE CO. SPALDING CO. TROUP CO. UPSON CO. 5-1 South Central (Dublin) BLECKLEY CO. DODGE CO. JOHNSON CO. LAURENS CO. MONTGOMERY CO. PULASKI CO. TELFAIR CO. TREUTLEN CO. WHEELER CO. WILCOX CO. 5-2 North Central (Macon) BALDWIN CO. BIBB CO. CRAWFORD CO. HANCOCK CO. HOUSTON CO. JASPER CO. JONES CO. MONROE CO. PEACH CO. PUTNAM CO. TWIGGS CO. 651 62.5 146 51.2 146 51.2 218 19.5 192 20.9 14 13.0 12 13.3 374 49.7 374 49.7 125 14.6 13 54.0 <5 -- 14 9.8 15 13.3 0 0.0 40 17.7 5 -- 0 0.0 <5 -- 12 18.4 9 12.9 <5 -- 25 16.6 <5 -- <5 -- <5 -- 9 -- 0 0.0 <5 -- 6 -- 0 0.0 0 0.0 0 0.0 99 18.8 8 -- 51 33.4 <5 -- <5 -- 25 16.3 0 0.0 0 0.0 0 0.0 5 -- 0 0.0 0 0.0 2017 Georgia HIV Surveillance Summary 16,770 2,708 2,708 4,091 3,362 381 348 9,926 9,926 2,155 100 263 273 198 12 749 43 52 18 210 168 69 612 55 93 26 197 14 22 92 22 39 53 2,203 147 1,193 29 25 408 22 52 48 120 35 25 1610.3 949.7 949.7 365.7 365.3 352.5 385.3 1317.8 1317.8 252.3 415.6 223.2 190.8 175.9 102.3 331.7 231.2 247.0 98.8 313.6 240.7 264.0 406.9 428.7 448.6 265.6 416.2 155.0 196.4 575.4 326.4 490.4 602.3 417.3 327.4 780.4 235.9 292.0 265.8 157.5 182.6 177.0 442.8 161.1 305.8 Page 39 WASHINGTON CO. WILKINSON CO. 6 East Central (Augusta) BURKE CO. COLUMBIA CO. EMANUEL CO. GLASCOCK CO. JEFFERSON CO. JENKINS CO. LINCOLN CO. MCDUFFIE CO. RICHMOND CO. SCREVEN CO. TALIAFERRO CO. WARREN CO. WILKES CO. 7 West Central (Columbus) CHATTAHOOCHEE CO. CLAY CO. CRISP CO. DOOLY CO. HARRIS CO. MACON CO. MARION CO. MUSCOGEE CO. QUITMAN CO. RANDOLPH CO. SCHLEY CO. STEWART CO.4 SUMTER CO. TALBOT CO. TAYLOR CO. WEBSTER CO. 8-1 South (Valdosta) BEN HILL CO. BERRIEN CO. BROOKS CO. COOK CO. ECHOLS CO. IRWIN CO. LANIER CO. LOWNDES CO. TIFT CO. TURNER CO. 8-2 Southwest (Albany) <5 -- <5 -- 91 18.7 <5 -- 13 8.6 5 -- 0 0.0 <5 -- <5 -- 0 0.0 <5 -- 62 30.7 <5 -- 0 0.0 0 0.0 <5 -- 119 32.4 0 0.0 0 0.0 5 -- <4 -- 4 -- 0 0.0 0 0.0 84 43.3 0 0.0 <5 -- <5 -- 9 -- 9 -- <5 -- <5 -- 0 0.0 68 26.5 0 0.0 0 0.0 <5 -- 0 0.0 0 0.0 <5 -- <5 -- 42 36.4 17 41.9 <5 -- 87 25.1 2017 Georgia HIV Surveillance Summary 78 21 2,257 89 200 58 4 56 40 15 56 1,640 48 3 20 28 1,806 13 17 123 54 54 45 13 1,149 12 37 7 94 137 19 30 2 1,151 57 47 51 53 8 64 19 646 171 34 1,779 384.0 234.4 464.3 395.2 131.9 257.4 0.5 456.3 190.4 662.7 812.7 344.0 377.1 283.1 492.1 125.7 573.9 541.0 393.1 159.2 338.0 153.8 592.1 508.9 523.0 1570.6 459.0 304.0 368.5 448.1 335.4 245.0 327.2 306.8 680.1 182.3 559.4 421.2 427.1 513.0 Page 40 BAKER CO. CALHOUN CO. COLQUITT CO. DECATUR CO. DOUGHERTY CO. EARLY CO. GRADY CO. LEE CO. MILLER CO. MITCHELL CO. SEMINOLE CO. TERRELL CO. THOMAS CO. WORTH CO. 9-1 Coastal (Savannah) BRYAN CO. CAMDEN CO. CHATHAM CO. EFFINGHAM CO. GLYNN CO. LIBERTY CO. LONG CO. MCINTOSH CO. 9-2 Southeast (Waycross) APPLING CO. ATKINSON CO. BACON CO. BRANTLEY CO. BULLOCH CO. CANDLER CO. CHARLTON CO. CLINCH CO. COFFEE CO. EVANS CO. JEFF DAVIS CO. PIERCE CO. TATTNALL CO. TOOMBS CO. WARE CO. WAYNE CO. 10 Northeast (Athens) BARROW CO. CLARKE CO. ELBERT CO. GREENE CO. 0 0.0 0 0.0 8 -- <5 -- 51 57.0 <5 -- <5 -- <5 -- 0 0.0 <5 -- 0 0.0 <5 -- 10 22.3 <5 -- 133 21.4 <5 -- <5 -- 91 31.3 6 -- 20 23.5 8 -- <5 -- <5 -- 45 12.2 <5 -- 0 0.0 <5 -- 0 0.0 12 15.8 <5 -- 7 -- <5 -- 7 -- 0 0.0 <5 -- <5 -- <5 -- <5 -- <5 -- <5 -- 54 10.8 7 -- 25 19.7 <5 -- <5 -- 2017 Georgia HIV Surveillance Summary 5 33 215 137 809 25 69 62 21 93 23 42 168 77 2,756 42 101 1,890 77 354 222 19 51 1,213 31 11 43 23 285 32 44 28 127 44 33 25 98 97 186 106 1,008 137 424 34 32 511.2 469.1 512.8 903.9 242.8 278.0 210.4 359.7 417.2 277.4 481.2 375.2 375.0 444.2 113.3 190.4 650.6 128.4 415.1 361.6 99.9 603.6 328.3 167.4 131.9 379.9 122.8 374.3 296.4 346.0 416.2 295.3 408.4 219.6 129.5 386.8 359.3 518.5 355.5 200.7 173.3 333.7 177.9 185.2 Page 41 JACKSON CO. MADISON CO. MORGAN CO. OCONEE CO. OGLETHORPE CO. WALTON CO. Unknown Health District 5 -- 0 0.0 <5 -- <5 -- <5 -- 7 -- 143 75 26 32 32 25 191 1,767 111.1 88.7 173.8 84.1 168.0 208.5 1. Cells <5 are not 2. Rates are not calculated when numerator is <12. 3. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. 4. Most cases associated with a federal detention center located in this county. 2017 Georgia HIV Surveillance Summary Page 42 Distribution of General Population by Race/Ethnicity Table 30. Distribution of the general population by race/ethnicity, Georgia 2017 Race/Ethnicity White, Non-Hispanic Black, Non-Hispanic Hispanic/Latino, Any Race Asian, Non-Hispanic American Indian /Alaskan Native, Non-Hispanic Native Hawaiian/Pacific Islander, Non-Hispanic Multiracial/Other, Non-Hispanic Total Number (%) 5,507,334 (53) 3,267,577 (31) 1,005,959 (9) 430,841 (4) 23,711 (<1) 6,339 (<1) 181,618 (2) 10,429,379 Source: Georgia Online Analytical Statistical Information System (https://oasis.state.ga.us/oasis/webquery/qryPopulation.aspx) 2017 Georgia HIV Surveillance Summary Page 43 HIV/AIDS RESOURCES: Georgia Department of Public Health http://dph.georgia.gov/what-hiv-and-aids Centers for Disease Control and Prevention http://www.cdc.gov/hiv/ AIDSVu http://aidsvu.org/ Reporting All health care providers diagnosing and/or providing care to a patient with HIV are required by Georgia law (O.C.G.A. 31-12-1) to report HIV infection using the HIV/AIDS Case Report Form. Case report forms should be completed within seven (7) days of diagnosing a patient with HIV and/or AIDS or within seven (7) days of assuming care of an HIV positive patient who is new to the provider, regardless of whether the patient has previously received care elsewhere. Adult and Pediatric case report forms are available at https://dph.georgia.gov/hivaids-case-reporting For more questions on HIV case reporting in Georgia please contact the HIV Surveillance Coordinator at 1800-827-9769 2017 Georgia HIV Surveillance Summary Page 44